行业分析 |
|
|
|
|
间充质干细胞治疗产品开发现状与趋势 |
毛开云, 范月蕾, 王跃, 陆娇, 陈大明 |
中国科学院上海生命科学信息中心 上海 200031 |
|
Development Status and Trend Analysis of Mesenchymal Stem Cells Therapeutic Products |
MAO Kai-yun, FAN Yue-lei, WANG Yue, LU Jiao, CHEN Da-ming |
Shanghai Information Center for Life Sciences, Chinese Academy of Sciences, Shanghai 200031, China |
引用本文:
毛开云, 范月蕾, 王跃, 陆娇, 陈大明. 间充质干细胞治疗产品开发现状与趋势[J]. 中国生物工程杂志, 2017, 37(10): 126-135.
MAO Kai-yun, FAN Yue-lei, WANG Yue, LU Jiao, CHEN Da-ming. Development Status and Trend Analysis of Mesenchymal Stem Cells Therapeutic Products. China Biotechnology, 2017, 37(10): 126-135.
链接本文:
https://manu60.magtech.com.cn/biotech/CN/10.13523/j.cb.20171017
或
https://manu60.magtech.com.cn/biotech/CN/Y2017/V37/I10/126
|
[1] |
秦彤,苗向阳.iPS细胞研究的新进展及应用.遗传,2010,32(12):1205-1214. Qin T,Miao X Y. New development and application of ips cell. Heredity,2010,32(12):1205-1214.
|
[2] |
Friedenstein A J, Petrakova K V, Kurolesova A I, et al. Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation, 1968,6(2):230-247.
|
[3] |
Friedenstein A J,Petrakova K V,Kurolesova A I. et al. Heterotopic of bone marrow. Analysisof precursor cells for osteogenic and hematopoietic tissues. Transplantation,1968,6(2):230-247.
|
[4] |
Lazarus H M,Haynesworth S E,Gerson S L,et al. Ex vivo expansion and subsequent infusion of human bone marrow-derivedstromal progenitor cells (mesenchymal progenitor cells):implications fortherapeutic use. Bone Marrow Transplant,1995,16(4):557-564.
|
[5] |
Pittenger M F, Mackay A M, Beck S C, et al. Multilineage potential of adult human mesenchymal stem cells. Science,1999,284(5411):143-147.
|
[6] |
Dominici M, Le Blanc K,Mueller I,et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The international society for cellular therapy position statement. Cytotherapy,2006,8(4):315-317.
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|